We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




ResMed Acquires Dutch Distributor

By HospiMedica staff writers
Posted on 28 Dec 2004
Print article
In a move to expand the company's operations, ResMed, Inc. (San Diego, CA, USA) has acquired Resprecare Medical B.V. (The Netherlands), its exclusive distributor there. ResMed will sell its respiratory products directly to the Dutch market through ResMed Nederland B.V., the new name of the company. Rene van den Heuvel, formerly the principal owner of Resprecare, will serve as managing director of the company. Terms of the transaction were not disclosed.

"This acquisition of our exclusive distributor fits our strategy for ongoing expansion of our international operations,” explained Peter C. Farrell, Ph.D., chairman and CEO of ResMed. "Most importantly, these acquisitions bring us closer to patients and allow us to better respond to their needs.”

ResMed is a leading manufacturer of medical equipment for the diagnosis, treatment, and management of sleep-disordered breathing, which is estimated to affect about 43 million people in the United States alone.




Related Links:
ResMed
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Automated External Defibrillator
HeartStart OnSite AED
New
LED Phototherapy System
neoBLUE compact

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.